secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enlightify Inc. (ENFY)
CIK:        0000857949
Form:       8-K/A
Filed at:   2025-06-05T23:59:59+00:00
Accession:  0001213900-25-051625
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enlightify amends 8-K to clarify Tianping Cai's board appointment, independent director terms
--------------------------------------------------------------------------------

- Appointment effective April 10, 2025, as board member, audit committee chair, and member of nominating/comp committees.
- Cai serves as Financial Director at HK Haoming International (medical device); prior risk management/audit at real estate firms.
- Independent Director Agreement signed June 5, 2025, provides $26,000 annual fee; supersedes prior Employment Agreement.
- Board determined Cai qualifies as audit committee financial expert and is independent under NYSE/SEC rules.
- Cai holds no beneficial ownership of ENFY stock and has no material interest in any transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/857949/000121390025051625/0001213900-25-051625-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/857949/000121390025051625/ea0244787-8ka1_enlightify.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-051625

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer